Free Trial
→ Elon's next millionaires start October 24? (From Behind the Markets) (Ad)tc pixel Free RZLT Stock Alerts

Rezolute (RZLT) Financials

Rezolute logo
$4.43 -0.18 (-3.80%)
As of 11:46 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Rezolute

Annual Income Statements for Rezolute

This table shows Rezolute's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Costs & Expenses		 - - - - - - - - - 80 83
Net Income / (Loss) Attributable to Common Shareholders		 -21 -24 -30 -33 -61 -21 -41 -52 -68 -74 -78
Consolidated Net Income / (Loss)		 -15 -20 -30 -30 -20 -21 -41 -52 -68 -74 -78
Net Income / (Loss) Continuing Operations		 -30 -41 -56 -30 -20 -21 -41 -52 -68 -74 -78
Total Pre-Tax Income 		-30 -41 -56 -30 -20 -21 -41 -52 -68 -74 -78
Total Operating Income		 -30 -41 -55 -26 -21 -23 -42 -56 -70 -80 -83
Total Gross Profit		 -9.61 -14 -23 -21 -8.26 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 -2.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 9.61 14 20 21 8.26 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 20 26 32 4.49 12 23 42 56 70 80 83
Selling, General & Admin Expense		 6.85 11 9.86 1.34 1.17 7.91 9.36 12 15 18 29
Research & Development Expense		 11 13 17 0.67 3.21 15 32 44 56 62 54
Total Other Income / (Expense), net		 0.02 0.05 -1.13 -4.50 0.19 1.99 0.78 4.21 1.96 5.48 5.38
Interest & Investment Income		 0.00 0.04 0.14 0.46 0.19 -0.31 -1.73 4.21 4.87 5.48 5.38
Basic Earnings per Share		 ($0.84) ($0.57) ($0.54) ($18.41) ($3.54) ($2.72) ($2.26) ($1.01) ($1.33) ($0.98) ($0.75)
Weighted Average Basic Shares Outstanding		 24.77M 41.30M 55.66M 1.78M 5.75M 7.67M 18.20M 51.19M 51.47M 76.00M 103.91M
Diluted Earnings per Share		 ($0.84) ($0.57) ($0.54) ($18.41) ($3.54) ($2.72) ($2.32) ($1.01) ($1.33) ($0.98) ($0.75)
Weighted Average Diluted Shares Outstanding		 24.77M 41.30M 55.66M 1.78M 5.75M 7.67M 19.49M 51.19M 51.47M 76.00M 103.91M
Weighted Average Basic & Diluted Shares Outstanding		 24.77M 41.30M 55.66M 1.78M 5.75M 7.67M 38.83M 36.83M 55.37M 90.81M 96.72M

Quarterly Income Statements for Rezolute

This table shows Rezolute's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Total Costs & Expenses		 - - - - - - - - - - 22
Net Income / (Loss) Attributable to Common Shareholders		 -14 -17 -23 -15 -16 -19 -24 -18 -23 -16 -20
Consolidated Net Income / (Loss)		 -14 -17 -23 -15 -16 -19 -24 -18 -23 -16 -20
Net Income / (Loss) Continuing Operations		 -14 -17 -23 -15 -16 -19 -24 -18 -23 -16 -20
Total Pre-Tax Income 		-14 -17 -23 -15 -16 -19 -24 -18 -23 -16 -20
Total Operating Income		 -15 -16 -23 -17 -17 -20 -26 -20 -24 -17 -22
Total Operating Expenses		 15 16 23 17 17 20 26 20 24 17 22
Selling, General & Admin Expense		 3.16 3.81 4.01 4.19 4.45 4.74 4.99 6.67 9.87 5.95 6.67
Research & Development Expense		 12 12 19 13 13 15 21 13 14 11 15
Total Other Income / (Expense), net		 1.29 -0.84 0.13 1.56 1.35 1.11 1.46 1.67 1.45 1.20 1.07
Interest & Investment Income		 1.30 1.12 1.04 1.58 1.34 1.12 1.45 1.68 1.45 1.20 1.06
Basic Earnings per Share		 ($0.27) ($0.34) ($0.44) ($0.22) ($0.22) ($0.27) ($0.27) ($0.18) ($0.22) ($0.16) ($0.19)
Weighted Average Basic Shares Outstanding		 51.41M 50.81M 51.47M 69.74M 69.94M 70.03M 76.00M 103.42M 103.69M 104.04M 103.91M
Diluted Earnings per Share		 ($0.27) ($0.34) ($0.44) ($0.22) ($0.22) ($0.27) ($0.27) ($0.18) ($0.22) ($0.16) ($0.19)
Weighted Average Diluted Shares Outstanding		 51.41M 50.81M 51.47M 69.74M 69.94M 70.03M 76.00M 103.42M 103.69M 104.04M 103.91M
Weighted Average Basic & Diluted Shares Outstanding		 39.63M 40.14M 55.37M 57.94M 60.54M 85.52M 90.81M 92.73M 95.70M 96.29M 96.72M

Annual Cash Flow Statements for Rezolute

This table details how cash moves in and out of Rezolute's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 -1.22 0.42 -2.84 9.93 -1.62 31 120 -134 54 24 -83
Net Cash From Operating Activities		 -10 -13 -14 -15 -24 -20 -40 -44 -57 -69 -65
Net Cash From Continuing Operating Activities		 -10 -13 -14 -15 -24 -20 -40 -44 -57 -69 -65
Net Income / (Loss) Continuing Operations		 -15 -20 -30 -30 -20 -21 -41 -52 -68 -74 -78
Consolidated Net Income / (Loss)		 -15 -20 -30 -30 -20 -21 -41 -52 -68 -74 -78
Depreciation Expense		 0.74 1.11 1.07 0.05 0.02 0.01 0.01 0.03 0.04 0.03 0.03
Amortization Expense		 0.01 0.01 - 2.05 - 0.00 2.50 -1.37 -2.84 -2.39 -2.45
Non-Cash Adjustments To Reconcile Net Income		 3.81 6.01 14 13 -3.05 0.76 -0.42 7.63 11 7.65 15
Changes in Operating Assets and Liabilities, net		 -0.12 -0.16 1.03 -0.14 -0.83 -0.31 -0.64 1.02 3.10 0.05 0.33
Net Cash From Investing Activities		 -1.45 -0.20 1.73 0.23 0.00 0.00 0.00 -101 49 -15 -21
Net Cash From Continuing Investing Activities		 -1.45 -0.20 1.73 0.23 0.00 0.00 0.00 -101 49 -15 -21
Purchase of Investments		 - - - - - - 0.00 -107 -66 -128 -178
Sale and/or Maturity of Investments		 - - - - - - 0.00 6.00 115 114 157
Net Cash From Financing Activities		 11 14 9.54 25 23 52 149 12 63 107 2.24
Net Cash From Continuing Financing Activities		 11 14 9.54 25 23 52 160 12 63 107 2.24
Repurchase of Common Equity		 -0.89 -0.68 -0.06 0.00 -1.50 - - 0.00 -0.32 -1.06 -0.04
Issuance of Common Equity		 5.36 15 4.50 0.00 24 41 180 12 63 107 0.00
Other Financing Activities, net		 -0.09 -0.02 0.00 25 0.00 -3.73 -3.72 -0.76 0.23 0.89 2.28

Quarterly Cash Flow Statements for Rezolute

This table details how cash moves in and out of Rezolute's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 4.45 -6.57 64 -60 -1.54 5.66 80 -85 2.85 -0.71 -0.62
Net Cash From Operating Activities		 -13 -15 -19 -16 -14 -17 -22 -17 -20 -14 -13
Net Cash From Continuing Operating Activities		 -13 -15 -19 -16 -14 -17 -22 -17 -20 -14 -13
Net Income / (Loss) Continuing Operations		 -14 -17 -23 -15 -16 -19 -24 -18 -23 -16 -20
Consolidated Net Income / (Loss)		 -14 -17 -23 -15 -16 -19 -24 -18 -23 -16 -20
Depreciation Expense		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Amortization Expense		 -2.15 -0.92 -0.74 -0.83 -0.73 -0.50 -0.34 -0.80 -0.71 -0.48 -0.46
Non-Cash Adjustments To Reconcile Net Income		 2.00 3.99 2.81 1.54 1.57 2.05 2.48 2.69 3.55 4.57 4.23
Changes in Operating Assets and Liabilities, net		 1.03 -1.27 2.37 -1.35 1.21 -0.04 0.23 -1.18 -0.40 -1.66 3.56
Net Cash From Investing Activities		 18 8.67 20 -49 11 23 0.35 -68 23 12 12
Net Cash From Continuing Investing Activities		 18 8.67 20 -49 11 23 0.35 -68 23 12 12
Purchase of Investments		 -24 -17 -9.67 -73 -25 -2.02 -27 -89 -27 -37 -25
Sale and/or Maturity of Investments		 42 25 29 24 37 25 28 20 50 49 38
Net Cash From Financing Activities		 -0.29 -0.00 63 5.50 0.66 0.01 101 0.91 0.36 0.75 0.23
Net Cash From Continuing Financing Activities		 -0.29 -0.00 63 5.50 0.66 0.01 101 0.91 0.36 0.75 0.23
Other Financing Activities, net		 - - 0.21 0.08 0.68 0.01 0.13 0.95 0.36 0.75 0.23

Annual Balance Sheets for Rezolute

This table presents Rezolute's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 11 11 2.50 12 11 43 152 124 133 175 113
Total Current Assets		 4.49 4.93 2.01 12 11 42 152 105 129 171 111
Cash & Equivalents		 4.06 4.49 1.65 12 9.96 41 150 16 70 94 11
Short-Term Investments		 - - - - - - 0.00 86 56 74 97
Prepaid Expenses		 - - 0.36 0.57 0.56 0.95 1.69 3.01 1.78 3.29 2.71
Plant, Property, & Equipment, net		 5.98 5.33 0.37 0.04 0.03 0.03 0.02 0.14 0.10 0.07 0.04
Total Noncurrent Assets		 0.43 0.37 0.13 0.06 0.41 0.59 0.30 19 3.98 4.27 2.30
Other Noncurrent Operating Assets		 0.38 0.33 0.09 0.04 0.41 0.59 0.30 2.20 3.72 4.27 2.30
Total Liabilities & Shareholders' Equity		 11 11 2.50 12 11 43 152 124 133 175 113
Total Liabilities		 2.13 2.10 6.46 11 3.60 17 2.95 7.55 12 13 12
Total Current Liabilities		 1.73 1.77 6.25 8.38 3.23 1.97 2.46 5.20 9.61 12 11
Accounts Payable		 1.50 0.95 1.85 0.56 0.89 1.04 1.13 3.27 4.90 5.81 5.03
Accrued Expenses		 - 0.70 - 0.00 0.19 0.24 1.22 0.51 2.33 3.20 3.70
Current Employee Benefit Liabilities		 - - 0.77 0.79 0.12 0.08 0.00 0.88 1.81 2.27 2.04
Other Current Liabilities		 0.13 0.11 0.19 7.03 2.03 0.61 0.11 0.54 0.57 0.63 0.66
Total Noncurrent Liabilities		 0.40 0.33 0.22 2.12 0.37 15 0.49 2.35 2.13 1.45 0.74
Other Noncurrent Operating Liabilities		 0.40 0.33 0.22 2.12 0.37 0.57 0.49 2.35 2.13 1.45 0.74
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 8.77 8.53 -3.96 1.75 7.37 26 149 116 121 162 101
Total Preferred & Common Equity		 8.77 8.53 -3.96 1.75 7.37 26 149 116 121 162 101
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 8.77 8.53 -3.96 1.75 7.37 26 149 116 121 162 101
Common Stock		 53 73 90 129 155 194 359 378 451 566 582
Retained Earnings		 -44 -64 -94 -127 -147 -168 -209 -261 -329 -404 -481
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - 0.00 -0.35 -0.08 -0.01 -0.12

Quarterly Balance Sheets for Rezolute

This table presents Rezolute's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 113 102 88 123 112 95 159 139 125
Total Current Assets		 103 96 82 110 99 89 155 135 122
Cash & Equivalents		 8.06 13 5.93 10 8.93 15 9.10 12 11
Short-Term Investments		 91 80 74 98 88 72 143 121 109
Prepaid Expenses		 3.92 3.49 2.19 1.91 2.15 1.84 2.51 2.17 1.78
Plant, Property, & Equipment, net		 0.13 0.12 0.11 0.10 0.09 0.08 0.06 0.06 0.05
Total Noncurrent Assets		 10 5.95 5.42 13 13 5.92 3.89 3.47 3.36
Other Noncurrent Operating Assets		 2.08 2.59 3.84 3.59 4.45 4.41 3.89 3.47 3.36
Total Liabilities & Shareholders' Equity		 113 102 88 123 112 95 159 139 125
Total Liabilities		 9.44 10 17 9.97 12 12 11 11 8.63
Total Current Liabilities		 7.20 8.01 6.96 7.99 11 11 10 9.53 7.70
Accounts Payable		 2.43 3.59 3.50 2.18 3.15 6.50 3.26 3.78 3.20
Accrued Expenses		 2.56 1.39 2.03 2.58 2.88 2.37 2.98 3.55 2.80
Current Employee Benefit Liabilities		 1.68 2.48 0.88 2.65 3.98 1.04 3.32 1.53 1.03
Other Current Liabilities		 0.53 0.54 0.55 0.58 0.60 0.62 0.65 0.67 0.67
Total Noncurrent Liabilities		 2.24 2.41 9.92 1.98 1.81 1.64 1.29 1.10 0.92
Other Noncurrent Operating Liabilities		 2.24 2.41 9.92 1.98 1.81 1.64 1.29 1.10 0.92
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 104 92 71 113 100 83 147 128 117
Total Preferred & Common Equity		 104 92 71 113 100 83 147 128 117
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 104 92 71 113 100 83 147 128 117
Common Stock		 379 381 377 458 460 462 569 573 578
Retained Earnings		 -276 -289 -306 -345 -361 -379 -422 -445 -461
Accumulated Other Comprehensive Income / (Loss)		 -0.28 -0.05 -0.08 0.29 0.06 0.04 0.05 0.05 -0.12

Annual Metrics And Ratios for Rezolute

This table displays calculated financial ratios and metrics derived from Rezolute's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 24,338,219.00 47,678,640.00 62,166,319.00 210,389,859.00 293,320,891.00 8,352,277.00 33,582,831.00 36,827,567.00 - 85,519,318.00 96,292,331.00
DEI Adjusted Shares Outstanding		 24,338,219.00 47,678,640.00 62,166,319.00 210,389,859.00 293,320,891.00 8,352,277.00 33,582,831.00 36,827,567.00 - 85,519,318.00 96,292,331.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.86 -0.50 -0.48 -0.16 -0.21 -2.50 -1.22 -1.42 - -0.87 -0.81
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -32.87% -35.67% -36.69% 55.87% 14.00% -0.36% -70.36% -63.55% -32.79% -8.05% -3.80%
EBIT Growth		 -35.47% -35.99% -35.56% 52.90% 20.90% -0.34% -82.43% -49.06% -30.97% -8.95% -3.85%
NOPAT Growth		 -39.76% -35.94% -35.59% 52.93% 20.90% -11.56% -82.77% -33.81% -25.78% -13.45% -3.85%
Net Income Growth		 -31.45% -35.76% -47.27% -1.96% 33.22% -2.80% -96.44% -26.13% -32.19% -8.70% -4.27%
EPS Growth		 -55.56% 32.14% 5.26% -3,309.26% 80.77% 23.16% 14.71% 56.47% -31.68% 26.32% 23.47%
Operating Cash Flow Growth		 -48.17% -26.91% -6.02% -8.44% -57.92% 15.42% -93.81% -12.28% -28.97% -20.41% 6.43%
Free Cash Flow Firm Growth		 -23.83% -24.62% -16.81% 67.51% -105.44% 18.34% -66.32% -29.34% -19.55% -24.19% -0.65%
Invested Capital Growth		 36.82% -15.70% -153.57% -352.16% 73.63% 62.16% 4.18% -133.65% -179.58% 6.57% -24.13%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 100.00% -100.00% -100.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -4.97% -13.47% -16.95% 63.57% -688.58% -40.77% 5.68% -11.88% -14.93% -1.75% 4.65%
EBIT Q/Q Growth		 -5.68% -13.08% -16.52% 60.54% -683.84% -40.73% -1.03% -5.54% -15.45% -2.33% 4.91%
NOPAT Q/Q Growth		 -5.47% -13.08% -16.56% 60.54% -683.84% -56.48% -12.54% -5.54% -14.40% -3.56% 4.91%
Net Income Q/Q Growth		 -5.89% -12.91% -26.75% 23.48% -2.01% -16.39% -7.69% -6.82% -17.60% -1.94% 4.78%
EPS Q/Q Growth		 -44.83% 30.49% -17.39% -2,568.12% 83.04% -7.09% 26.35% -44.29% -15.65% 14.78% 9.64%
Operating Cash Flow Q/Q Growth		 -12.78% -3.84% -1.72% 0.76% -1.31% -5.97% -21.02% 1.68% -14.29% -5.29% 12.04%
Free Cash Flow Firm Q/Q Growth		 3.03% -11.32% -6.20% 69.03% -145.20% -59.00% 7.35% -17.08% -32.18% 4.36% 10.69%
Invested Capital Q/Q Growth		 11.43% 0.44% -254.86% 8.06% 30.13% 65.70% -133.81% -12.17% 42.85% 1.82% -107.16%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 49.97% 49.94% 53.10% 100.00% 100.00% 100.00% 100.00% 100.01% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.01% 99.91% 102.09% 117.35% 99.08% 101.52% 109.31% 92.48% 93.36% 93.14% 93.52%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -167.56% -234.41% -1,307.74% 2,756.54% -446.05% -124.92% -46.77% -38.99% -57.73% -52.56% -59.04%
Cash Return on Invested Capital (CROIC)		 -534.02% -625.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -167.56% -234.41% -1,307.74% 2,756.54% -446.05% -124.92% -46.77% -38.99% -57.73% -52.56% -59.04%
Return on Equity Simple (ROE_SIMPLE)		 -170.25% -237.77% 753.90% -1,737.79% -276.08% -80.09% -27.47% -44.58% -56.58% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -21 -28 -39 -18 -14 -16 -29 -39 -49 -56 -58
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 126.20% 193.81% 649.42% -251.13% -55.45% -26.33% -13.26% -9.37% -15.61% -12.53% -14.16%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - -34.50% -57.68%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -30 -41 -55 -26 -21 -21 -38 -56 -73 -80 -83
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -29 -40 -54 -24 -21 -21 -35 -57 -76 -82 -85
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 23.78 2.81 4.57 0.73 0.63 1.43 2.35 4.97
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 24.18 2.81 4.57 0.73 0.63 1.43 2.35 4.97
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.00 -0.87 0.00 0.00 0.54 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.54 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.53 -0.49 -0.59 4.43 -2.36 -1.11 -1.01 -1.01 -1.04 -1.04 -1.05
Leverage Ratio		 1.24 1.24 2.88 -6.68 2.55 1.60 1.11 1.04 1.08 1.09 1.10
Compound Leverage Factor		 1.24 1.24 2.94 -7.84 2.52 1.63 1.21 0.96 1.01 1.01 1.03
Debt to Total Capital		 0.94% 0.12% -653.04% 0.00% 0.00% 34.86% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.94% 0.12% -653.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 34.86% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.06% 99.88% 753.04% 100.00% 100.00% 65.14% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 -0.06 0.00 0.00 -0.68 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.14 0.11 -0.03 0.00 0.00 1.32 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.68 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 -0.09 0.00 0.00 -0.87 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.19 0.16 -0.05 0.00 0.00 1.69 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.87 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 -125.78 -18.74 -20.73 -1.66 20.51 2.32 4.60 13.49 17.36
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.60 2.78 0.32 1.45 3.26 21.34 61.78 20.18 13.39 14.37 9.68
Quick Ratio		 2.35 2.53 0.26 1.38 3.09 20.86 61.09 19.60 13.21 14.09 9.44
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -22 -28 -32 -11 -22 -18 -29 -38 -45 -56 -57
Operating Cash Flow to CapEx		 -501.41% -3,263.18% 0.00% 0.00% 0.00% 0.00% 0.00% -29,072.55% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -4,410.77 -17,366.03 -25.06 -2.12 0.00 0.00 -16.56 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -2,081.46 -8,345.74 -10.93 -3.09 0.00 0.00 -22.37 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -2,496.58 -8,601.50 -9.74 -3.04 0.00 0.00 -22.37 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 6.61 11.67 14.39 17.76 11.34 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 55.26 31.28 25.36 20.56 32.18 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4.81 4.05 -2.17 -9.82 -2.59 -0.98 -0.94 -2.19 -6.13 -5.73 -7.11
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 1.29 -0.75 -6.23 -7.65 7.23 1.61 0.04 -1.26 -3.94 0.40 -1.38
Enterprise Value (EV)		 0.00 0.00 30 30 11 92 -42 -45 45 214 393
Market Capitalization		 0.00 0.00 28 42 21 119 108 73 173 381 501
Book Value per Share		 $0.36 $0.18 ($0.06) $0.01 $0.03 $3.12 $4.45 $3.15 $3.01 $1.90 $1.05
Tangible Book Value per Share		 $0.36 $0.18 ($0.06) $0.01 $0.03 $3.12 $4.45 $3.15 $3.01 $1.90 $1.05
Total Capital		 8.86 8.54 -0.53 1.75 7.37 40 149 116 121 162 101
Total Debt		 0.08 0.01 3.44 0.00 0.00 14 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 14 0.00 0.00 0.00 0.00 0.00
Net Debt		 -3.98 -4.48 1.79 -12 -9.96 -27 -150 -118 -127 -168 -108
Capital Expenditures (CapEx)		 2.09 0.41 -1.54 -0.23 0.00 0.00 0.00 0.15 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.22 -1.32 -2.45 -7.81 -2.66 -1.02 -0.77 -2.19 -7.83 -8.63 -8.71
Debt-free Net Working Capital (DFNWC)		 2.84 3.17 -0.81 3.77 7.29 40 150 100 119 159 99
Net Working Capital (NWC)		 2.76 3.16 -4.24 3.77 7.29 40 150 100 119 159 99
Net Nonoperating Expense (NNE)		 -6.00 -8.18 -8.72 12 5.97 4.88 12 13 19 18 20
Net Nonoperating Obligations (NNO)		 -3.96 -4.47 1.79 -12 -9.96 -27 -150 -118 -127 -168 -108
Total Depreciation and Amortization (D&A)		 0.75 1.11 1.07 2.10 0.02 0.01 2.51 -1.34 -2.80 -2.36 -2.42
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.84) ($0.57) ($0.53) ($0.37) ($3.54) ($2.72) ($2.26) ($1.01) ($1.33) ($0.98) ($0.75)
Adjusted Weighted Average Basic Shares Outstanding		 35.53M 53.73M 55.66M 293.32M 5.75M 8.62M 18.20M 51.19M 51.47M 76.00M 103.91M
Adjusted Diluted Earnings per Share		 ($0.84) ($0.57) ($0.53) ($0.37) ($3.54) ($2.72) ($2.32) ($1.01) ($1.33) ($0.98) ($0.75)
Adjusted Weighted Average Diluted Shares Outstanding		 35.53M 53.73M 55.66M 293.32M 5.75M 8.62M 19.49M 51.19M 51.47M 76.00M 103.91M
Adjusted Basic & Diluted Earnings per Share		 ($0.84) ($0.57) ($0.53) ($0.37) ($3.54) ($2.72) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 24.77M 41.30M 55.65M 88.87M 5.75M 7.67M 38.83M 36.83M 55.37M 90.81M 96.72M
Normalized Net Operating Profit after Tax (NOPAT)		 -21 -28 -37 -18 -14 -16 -29 -39 -49 -56 -58
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -5,930.30 -25,477.57 -42.67 -5.23 0.00 0.00 -21.21 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -4,153.96 -17,839.29 -29.88 -3.66 0.00 0.00 -16.54 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -6,345.42 -25,733.33 -41.47 -5.19 0.00 0.00 -21.21 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -4,569.08 -18,095.04 -28.69 -3.62 0.00 0.00 -16.54 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -5.96% -3.37% -0.20% 0.00% -7.38% 0.00% 0.00% 0.00% 0.00% -1.42% -0.05%

Quarterly Metrics And Ratios for Rezolute

This table displays calculated financial ratios and metrics derived from Rezolute's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 39,625,271.00 39,625,271.00 - - - 60,535,425.00 85,519,318.00 90,811,368.00 92,727,532.00 95,697,685.00 96,292,331.00
DEI Adjusted Shares Outstanding		 39,625,271.00 39,625,271.00 - - - 60,535,425.00 85,519,318.00 90,811,368.00 92,727,532.00 95,697,685.00 96,292,331.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.35 -0.43 - - - -0.31 -0.29 -0.20 -0.25 -0.17 -0.21
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -20.54% -6.88% -66.64% -18.97% -2.51% -7.56% -5.72% -15.98% -40.13% 13.08% 15.92%
EBIT Growth		 -5.60% -5.92% -69.16% -6.45% -12.24% -10.22% -7.57% -16.96% -41.86% 13.30% 16.59%
NOPAT Growth		 -5.57% 5.42% -62.26% -6.45% -12.41% -23.50% -11.90% -16.98% -41.81% 13.27% 16.59%
Net Income Growth		 -2.60% -8.79% -80.52% -5.88% -13.09% -10.93% -6.15% -18.03% -44.78% 14.50% 15.99%
EPS Growth		 -3.85% -13.33% -69.23% 21.43% 18.52% 20.59% 38.64% 18.18% 0.00% 40.74% 29.63%
Operating Cash Flow Growth		 -73.76% 15.56% -63.19% -51.29% -4.96% -14.17% -18.75% -8.84% -48.72% 21.06% 40.23%
Free Cash Flow Firm Growth		 -114.19% 64.62% -40.40% -19.01% 12.13% -635.60% -51.23% -22.67% -69.74% 23.02% 25.88%
Invested Capital Growth		 22.97% -448.77% -179.58% -32.45% -35.62% 45.62% 6.57% -14.64% 13.73% 41.17% -24.13%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -16.13% -9.94% -29.69% 28.15% -0.06% -15.37% -27.47% 21.17% -20.87% 28.44% -23.38%
EBIT Q/Q Growth		 4.50% -19.46% -32.16% 29.40% -0.70% -17.31% -28.99% 23.24% -22.13% 28.30% -24.16%
NOPAT Q/Q Growth		 4.52% -6.71% -42.49% 26.67% -0.82% -17.23% -29.10% 23.34% -22.22% 28.30% -24.16%
Net Income Q/Q Growth		 4.23% -22.58% -34.76% 33.07% -2.29% -20.24% -28.95% 25.58% -25.48% 28.99% -26.71%
EPS Q/Q Growth		 3.57% -25.93% -29.41% 50.00% 0.00% -22.73% 0.00% 33.33% -22.22% 27.27% -18.75%
Operating Cash Flow Q/Q Growth		 -23.00% -17.06% -21.53% 13.54% 14.66% -27.32% -26.41% 20.75% -16.60% 32.42% 4.29%
Free Cash Flow Firm Q/Q Growth		 -31.26% 78.38% -375.73% 11.83% 3.08% -80.95% 2.19% 28.48% -34.10% 17.93% 5.83%
Invested Capital Q/Q Growth		 -27.55% -154.24% 42.85% 28.53% -30.61% -1.94% 1.82% 12.30% 1.71% 30.49% -107.16%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 91.43% 93.83% 95.67% 90.69% 92.13% 94.43% 94.41% 91.52% 94.03% 93.12% 95.03%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -48.79% -58.75% -57.73% -63.88% -74.36% -95.15% -52.56% -59.23% -74.02% -81.73% -59.04%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -48.79% -58.75% -57.73% -63.88% -74.36% -95.15% -52.56% -59.23% -74.02% -81.73% -59.04%
Return on Equity Simple (ROE_SIMPLE)		 -61.96% -82.15% 0.00% -61.10% -71.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -11 -11 -16 -12 -12 -14 -18 -14 -17 -12 -15
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -2.70% -5.41% -5.54% -3.13% -3.75% -5.76% -4.27% -3.17% -4.89% -3.85% -3.92%
Return On Investment Capital (ROIC_SIMPLE)		 -11.59% -16.02% - - -12.01% -16.98% -11.16% -9.43% -13.25% -10.40% -14.99%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -15 -18 -24 -17 -17 -20 -26 -20 -24 -17 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -17 -19 -25 -18 -18 -21 -26 -21 -25 -18 -22
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.43 1.43 1.43 2.37 2.85 2.13 2.35 5.80 1.71 2.50 4.97
Price to Tangible Book Value (P/TBV)		 0.43 1.43 1.43 2.37 2.85 2.13 2.35 5.80 1.71 2.50 4.97
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.04 -1.06 -1.04 -1.04 -1.05 -1.11 -1.04 -1.04 -1.05 -1.05 -1.05
Leverage Ratio		 1.08 1.12 1.08 1.09 1.12 1.19 1.09 1.08 1.10 1.10 1.10
Compound Leverage Factor		 0.99 1.05 1.03 0.99 1.03 1.12 1.03 0.99 1.04 1.03 1.04
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -1.16 -0.95 5.83 12.78 9.65 3.34 14.51 41.51 8.37 15.80 19.15
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 12.00 11.82 13.39 13.79 9.30 8.43 14.37 15.15 14.18 15.84 9.68
Quick Ratio		 11.56 11.50 13.21 13.55 9.10 8.25 14.09 14.91 13.95 15.61 9.44
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -12 -2.57 -12 -11 -10 -19 -18 -13 -18 -15 -14
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -4.22 -11 -6.13 -4.38 -5.73 -5.84 -5.73 -5.03 -4.94 -3.43 -7.11
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 1.26 -8.78 -3.94 -1.07 -1.50 4.90 0.40 -0.64 0.79 2.40 -1.38
Enterprise Value (EV)		 -57 19 45 151 179 87 214 701 86 172 393
Market Capitalization		 39 101 173 269 284 176 381 854 219 292 501
Book Value per Share		 $2.31 $1.79 $3.01 $2.05 $1.72 $1.36 $1.90 $1.62 $1.38 $1.22 $1.05
Tangible Book Value per Share		 $2.31 $1.79 $3.01 $2.05 $1.72 $1.36 $1.90 $1.62 $1.38 $1.22 $1.05
Total Capital		 92 71 121 113 100 83 162 147 128 117 101
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -96 -82 -127 -118 -105 -88 -168 -152 -133 -120 -108
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -4.52 -4.77 -7.83 -6.09 -8.45 -8.68 -8.63 -7.70 -7.36 -5.92 -8.71
Debt-free Net Working Capital (DFNWC)		 88 75 119 102 88 78 159 144 126 114 99
Net Working Capital (NWC)		 88 75 119 102 88 78 159 144 126 114 99
Net Nonoperating Expense (NNE)		 3.27 5.70 6.80 3.52 3.77 4.90 6.30 4.28 5.82 4.01 5.40
Net Nonoperating Obligations (NNO)		 -96 -82 -127 -118 -105 -88 -168 -152 -133 -120 -108
Total Depreciation and Amortization (D&A)		 -2.14 -0.91 -0.73 -0.82 -0.72 -0.50 -0.33 -0.79 -0.71 -0.47 -0.45
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.27) ($0.34) ($0.44) ($0.22) ($0.22) ($0.27) ($0.27) ($0.18) ($0.22) ($0.16) ($0.19)
Adjusted Weighted Average Basic Shares Outstanding		 51.41M 50.81M 51.47M 69.74M 69.94M 70.03M 76.00M 103.42M 103.69M 104.04M 103.91M
Adjusted Diluted Earnings per Share		 ($0.27) ($0.34) ($0.44) ($0.22) ($0.22) ($0.27) ($0.27) ($0.18) ($0.22) ($0.16) ($0.19)
Adjusted Weighted Average Diluted Shares Outstanding		 51.41M 50.81M 51.47M 69.74M 69.94M 70.03M 76.00M 103.42M 103.69M 104.04M 103.91M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 39.63M 40.14M 55.37M 57.94M 60.54M 85.52M 90.81M 92.73M 95.70M 96.29M 96.72M
Normalized Net Operating Profit after Tax (NOPAT)		 -11 -11 -16 -12 -12 -14 -18 -14 -17 -12 -15
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -0.51% 0.00% -0.84% -0.43% -0.84% -1.42% -0.67% -0.59% -0.61% -0.05%

Financials Breakdown Chart

Key Financial Trends

Rezolute (NASDAQ:RZLT) remains a development-stage biotechnology company with no reported revenue across the periods provided. Its financial profile is therefore driven primarily by research spending, investment income, equity financing and cash consumption rather than commercial operations.

  • Strong near-term liquidity: As of March 31, 2026, Rezolute reported $12.2 million of cash and $109.0 million of short-term investments, or approximately $121.2 million in readily available current liquidity. Total liabilities were only $8.6 million, producing a current ratio of roughly 15.8.
  • Operating cash usage has been relatively stable: Quarterly operating cash outflow ranged from $13.1 million to $20.3 million during fiscal 2026, with the latest quarter at $13.1 million. Based on the fiscal 2026 quarterly average, the company was using approximately $16.2 million of operating cash per quarter.
  • Investment income provides a modest offset: Interest and investment income remained between approximately $1.0 million and $1.7 million per quarter throughout the reported periods. This income helps reduce net losses, although it does not replace operating revenue.
  • Debt exposure appears limited: Rezolute reported no preferred stock and relatively low total liabilities compared with equity and liquid assets. This gives the company more financial flexibility than a heavily debt-funded development-stage business.
  • Investment portfolio management has supported cash balances: Rezolute regularly sold or allowed investments to mature while purchasing new investments. In the fourth quarter of fiscal 2026, investment activity generated $12.3 million of net cash, which helped offset operating cash consumption.
  • Research spending remains the primary use of capital: Research and development expense was $14.9 million in the fourth quarter of fiscal 2026, up from $11.4 million in the prior quarter and $12.8 million in the fourth quarter of fiscal 2025. The higher spending may reflect increased development activity, but it also raises the company’s cash needs.
  • Cash reserves have declined from the start of fiscal 2026: Cash and short-term investments totaled approximately $152.2 million at September 30, 2025, compared with approximately $121.4 million at March 31, 2026. The balance remains substantial, but the direction reflects ongoing funding requirements.
  • Rezolute continues to report recurring losses: Net loss was $20.5 million in the fourth quarter of fiscal 2026, compared with $16.2 million in the third quarter and $22.8 million in the second quarter. The company has not yet demonstrated a path to profitability.
  • Operating expenses increased in the latest quarter: Total operating expenses rose to $21.6 million in the fourth quarter of fiscal 2026 from $17.4 million in the third quarter. SG&A increased to $6.7 million, while R&D increased to $14.9 million.
  • Share dilution is a continuing risk: Weighted average basic shares increased to approximately 103.9 million in the fourth quarter of fiscal 2026 from 76.0 million in the fourth quarter of fiscal 2025. Rezolute also reported $101.5 million of common equity issuance in the fourth quarter of fiscal 2025, indicating that future capital raises could dilute existing shareholders.

Income statement trend: Rezolute reported zero revenue in every income statement period provided. Quarterly operating losses generally widened from approximately $15.2 million to $17.1 million in fiscal 2024 to approximately $19.8 million to $25.9 million in fiscal 2025, before reaching $21.6 million in the fourth quarter of fiscal 2026. Investment income has consistently reduced the loss, but it has not been large enough to overcome operating expenses.

Cash flow trend: Operating cash flow has been negative in every reported quarter, demonstrating that Rezolute’s research and corporate activities are being funded by existing cash, investment maturities and equity financing. Fiscal 2026 operating cash outflows totaled approximately $64.6 million through the fourth quarter based on the quarterly figures supplied. The fourth quarter’s overall cash decline was limited to $621,000 because net investment proceeds and modest financing inflows largely offset the operating deficit.

Balance sheet trend: Total assets declined from $158.7 million at September 30, 2025, to $125.5 million at March 31, 2026, primarily reflecting lower cash and short-term investments. Even so, the balance sheet remained lightly leveraged, with $8.6 million of liabilities against $116.8 million of common equity. Retained earnings were deeply negative at $(461.0) million, reflecting the company’s accumulated history of losses.

Overall, Rezolute’s statements show a company with a comparatively strong liquidity position and limited debt, but one that remains fully dependent on outside capital and investment reserves because it has no revenue and continues to consume cash. The key issues for investors are the pace of clinical and R&D spending, the timing of potential commercialization and the possibility of additional equity financing and dilution.

10/14/26 08:50 AM ETAI Generated. May Contain Errors.

Rezolute Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Rezolute's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Rezolute's net income appears to be on a downward trend, with a most recent value of -$77.59 million in 2026, falling from -$14.94 million in 2016. The previous period was -$74.41 million in 2025. See Rezolute's forecast for analyst expectations on what's next for the company.

Rezolute's total operating income in 2026 was -$82.97 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $82.97 million

Over the last 10 years, Rezolute's total revenue changed from $0.00 in 2016 to $0.00 in 2026, a change of 0.0%.

In the past 10 quarters, Rezolute's cash and equivalents has ranged from $5.93 million in Q3 2024 to $14.60 million in Q3 2025, and is currently $11.24 million as of their latest financial filing in Q3 2026.

Rezolute had total debt of $0.00 at the end of 2026, compared with none in 2025, and a 100.0% decrease since 2016.

Over the last 10 years, Rezolute's book value per share changed from 0.36 in 2016 to 1.05 in 2026, a change of 190.0%.


Related Companies

Financial statements for NASDAQ:RZLT last updated on 9/24/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...
Chaikin Analytics | Sponsoredtc pixel
The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...
Behind the Markets | Sponsoredtc pixel
How one AI fund pays investors every Thursday
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...
Paradigm Press | Sponsoredtc pixel
Federal Reserve Reveals Disturbing New Plan To Control Your Money
A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...
Weiss Ratings | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel